Clinical Trial Update: A Non-interventional Prospective Study of 1-st Line Treatment Approaches in OVArian Cancer Patients With HRD+ Status in Russian Federation

View source ↗

Summary

A non-interventional prospective study evaluating first-line treatment approaches for HRD-positive ovarian cancer patients in the Russian Federation; the trial …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Snippet

Sponsor: AstraZeneca | Conditions: Ovarian Cancer | Status: ACTIVE_NOT_RECRUITING